Advanced search
Publication Cover
Drug Design, Development and Therapy Volume 15, 2021 - Issue
Submit an article Journal homepage
122
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Method Development and Validation for Measuring O6-Methylguanine in Dried Blood Spot Using Ultra High-Performance Liquid Chromatography Tandem Mass Spectrometry

Yahdiana Harahap1 Faculty of Pharmacy, Universitas Indonesia, Depok, West Java, 16424, Indonesia;2 Indonesia Defense University, Bogor, 16810, West Java, IndonesiaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7217-7900
ORCID Icon,
Aurelia Maria Vianney1 Faculty of Pharmacy, Universitas Indonesia, Depok, West Java, 16424, Indonesia
&
Herman Suryadi1 Faculty of Pharmacy, Universitas Indonesia, Depok, West Java, 16424, Indonesia
Pages 963-971 | Published online: 03 Mar 2021

References

  • ReddyH, DuffyA, HoltzmanNG, EmadiA. The role of β-elimination for the clinical activity of hypomethylating agents and cyclophosphamide analogues. Am J Cancer Ther Pharm. 2016;3:1–8.
  • TimmR, KaiserR, LotschJ, et al. Association of cyclophosphamide pharmacokinetics to polymorphic cytochrome P450 2C19. Pharmacogenomics J. 2005;5(6):365–373. doi:10.1038/sj.tpj.650033016116487
  • International Agency for Research on Cancer. IARC monograph - 100A. Paris: International Agency for Research on Cancer; 2012.
  • RobertJFH, BastC Jr, GroceCM, et al. Holland-Frei Cancer Medicine. 9th ed. Vol. 2016. Hoboken, New Jersey: JohnWiley & Sons, Inc.; 2017.
  • KatzungBG, TrevorAJ. Basic & Clinical Pharmacology, Thirteenth. San Fransisco: McGraw-Hill Education; 2015.
  • WilhelmAJ, den BurgerJCG, SwartEL. Therapeutic drug monitoring by dried blood spot: progress to date and future directions. Clin Pharmacokinet. 2014;53:961–973. doi:10.1007/s40262-014-0177-725204403
  • HarahapY, AndalusiaR, CrystaliaY, NurfaradillaS. Analysis of O6-methylguanine in cancer patient blood during administration of cyclophosphamide using ultra high performance liquid chromatography-tandem mass spectrometry. J Adv Med Pharm Sci. 2015;2:20–28. doi:10.9734/jamps/2015/12953
  • OstlerMW, PorterJH, BuxtonOM. Dried blood spot collection of health biomarkers to maximize participation in population studies. J Vis Exp. 2014;1–9. doi:10.3791/50973
  • KimHM, ParkJ, Phuoc LongN, KimD, KwonSW. Simultaneous determination of cardiovascular drugs in dried blood spot by liquid chromatography-tandem mass spectrometry. J Food Drug Anal. 2019;27:906–914. doi:10.1016/j.jfda.2019.06.00131590762
  • Food and Drug Administration. Bioanalytical method validation guidance. Food Drug Adm. 2018;1043:25.
  • QIAGEN. QIAamp DNA mini and blood mini handbook Qiagen; 2016:1–72. Available from: http://www.qiagen.com/knowledge-and-support/resource-center/resource-download.aspx?id=67893a91-946f-49b5-8033-394fa5d752ea&lang=en. Accessed 218, 2021.
  • LiW, ZhangJ, FrancisLST. Handbook of LC-MS Bioanalysis. Canada: John Wiley & Sons, Inc.; 2013.
  • Van De MerbelN, SavoieN, YadavM, et al. Stability: recommendation for best practices and harmonization from the global bioanalysis consortium harmonization team. AAPS J. 2014;16:392–399. doi:10.1208/s12248-014-9573-z24550081
  • BriscoeCJ, StilesMR, HageDS. System suitability in bioanalytical LC/MS/MS. J Pharm Biomed Anal. 2007;44:484–491. doi:10.1016/j.jpba.2007.03.00317433601
  • GhatolS, VithlaniV, GuruleS, KhurooA, MonifT, PartaniP. Liquid chromatography tandem mass spectrometry method for the estimation of lamotrigine in human plasma: application to a pharmacokinetic study. J Pharm Anal. 2013;3:75–83. doi:10.1016/j.jpha.2012.09.00129403800

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.